John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
KBR
KBR
$4.86B
| $31.3M | 0.07% |
629,012
+581,082
| +1,212% | +$31M |
|
327
TG Therapeutics
TGTX
$8.31B
| $31.3M | 0.07% |
793,639
+187,431
| +31% | +$6.31M |
|
328
iShares S&P 500 Value ETF
IVE
$50.2B
| $31.2M | 0.07% |
163,800
+128,900
| +369% | +$24.9M |
|
329
Sterling Infrastructure
STRL
$15.8B
| $31.2M | 0.07% |
275,243
+207,830
| +308% | +$29.3M |
|
330
Insmed
INSM
$27.5B
| $31M | 0.07% |
406,903
-187,093
| -31% | -$14.3M |
|
331
M&T Bank
MTB
$34.7B
| $30.9M | 0.07% |
172,926
+135,109
| +357% | +$25.6M |
|
332
ADT
ADT
$5.39B
| $30.9M | 0.07% |
3,795,582
+2,991,106
| +372% | +$22.6M |
|
333
Allstate
ALL
$64.2B
| $30.9M | 0.07% |
149,044
+11,994
| +9% | +$2.34M |
|
|
GTM
334
ZoomInfo Technologies
GTM
$1.16B
| $30.8M | 0.07% |
3,082,184
+882,871
| +40% | +$9.26M |
|
335
Gulfport Energy Corp
GPOR
$3.07B
| $30M | 0.06% |
163,018
+65,321
| +67% | +$11.9M |
|
|
EMBJ
336
Embraer S.A. ADS
EMBJ
$13.5B
| $30M | 0.06% |
649,737
+143,686
| +28% | +$6.4M |
|
|
GAP
337
The Gap Inc
GAP
$7.13B
| $29.8M | 0.06% |
1,448,153
-1,145,929
| -44% | -$25.8M |
|
|
CNH
338
CNH Industrial
CNH
$19.1B
| $29.6M | 0.06% |
2,413,220
+2,297,376
| +1,983% | +$28.8M |
|
339
Kinder Morgan
KMI
$69B
| $29.6M | 0.06% |
+1,038,399
| New | +$28.8M |
|
340
Owens Corning
OC
$11.7B
| $29.6M | 0.06% |
+207,177
| New | +$34.2M |
|
341
Generac Holdings
GNRC
$12.2B
| $29.5M | 0.06% |
233,137
+70,420
| +43% | +$10.1M |
|
342
Bilibili
BILI
$7.14B
| $29.3M | 0.06% |
1,535,049
+113,076
| +8% | +$2.17M |
|
343
Albemarle Corp Depositary Shares
ALB.PRA
$2.66B
| $29.2M | 0.06% |
819,127
-849,006
| -51% | -$33.5M |
|
344
Popular Inc
BPOP
$10.8B
| $29.2M | 0.06% |
315,981
+66,288
| +27% | +$6.45M |
|
345
SiriusXM
SIRI
$9.67B
| $29.2M | 0.06% |
1,294,484
+1,265,101
| +4,306% | +$29.8M |
|
346
BridgeBio Pharma
BBIO
$15.9B
| $29.2M | 0.06% |
843,321
+604,785
| +254% | +$20.4M |
|
347
Accenture
ACN
$113B
| $29.1M | 0.06% |
93,205
+83,505
| +861% | +$29.5M |
|
348
Bank OZK
OZK
$5.39B
| $29.1M | 0.06% |
668,843
+2,249
| +0.3% | +$106K |
|
349
iShares ESG Aware MSCI USA ETF
ESGU
$18.1B
| $28.9M | 0.06% |
236,900
-65,400
| -22% | -$8.42M |
|
350
Tetra Tech
TTEK
$9.47B
| $28.9M | 0.06% |
986,937
+484,890
| +97% | +$16.3M |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.